Answers are grounded in this paper and cite their sources.
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent inflammation and progressive joint damage. We isolated and purified moxa smoke-derived carbon dots (ACDs) using a smoldering-combustion aerosol-capture route, characterized their physicochemical properties, and evaluated their anti-inflammatory and anti-arthritic effects in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages and a rat model of collagen-induced arthritis (CIA). ACDs were well-dispersed, quasi-spherical nanoparticles (1.9–4.0 nm; mean, 2.9 nm) containing locally ordered sp 2 -carbon domains and oxygen- and nitrogen-containing surface groups. At concentrations ≤150 μg/mL, ACDs did not compromise RAW264.7 cell viability and attenuated LPS-evoked nitric oxide (NO) generation and IL-6 release. In CIA rats, ACDs improved clinical and histological manifestations, including arthritis scores, ankle swelling, synovial hyperplasia, inflammatory infiltration, and cartilage injury, and decreased serum NO, PGE 2 , TNF-α, IL-1β, IL-6, and IL-18. ACD treatment was also associated with reduced p38 MAPK and NF-κB phosphorylation and decreased NLRP3, ASC, cleaved caspase-1, and GSDMD-NT expression. These findings demonstrate the anti-inflammatory and anti-arthritic activity of ACDs and support further investigation of their biological effects in RA.
No takes yet. Share an insight, caveat, or question.
Bilin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: